Secnidazole: Advanced Single-Dose Treatment for Protozoal and Bacterial Infections

Secnidazole

Product dosage: 1 gr
Package (num)	Per pill	Price	Buy
20	$2.76	$55.25 (0%)	🛒 Add to cart
30	$2.24	$82.87 $67.30 (19%)	🛒 Add to cart
60	$1.59	$165.74 $95.43 (42%)	🛒 Add to cart
120	$1.11 Best per pill	$331.49 $133.60 (60%)	🛒 Add to cart
Synonyms Solosec

Show more

Secnidazole is a next-generation nitroimidazole antimicrobial agent specifically designed to target anaerobic bacteria and protozoa. It offers a potent, broad-spectrum mechanism of action with the distinct advantage of an extended plasma half-life, enabling effective single-dose or short-course regimens. This pharmacokinetic profile enhances patient adherence, reduces the risk of incomplete treatment, and provides sustained therapeutic concentrations at infection sites. Its efficacy is well-established in the management of bacterial vaginosis, amoebiasis, giardiasis, and trichomoniasis, positioning it as a valuable therapeutic option in both gastroenterology and gynecology.

Features

• Active Ingredient: Secnidazole
• Drug Class: Nitroimidazole antimicrobial
• Available Forms: Oral granules (in sachets), tablets
• Mechanism of Action: Prodrug activated by anaerobic metabolism; causes cytotoxic damage to microbial DNA
• Spectrum of Activity: Broad coverage against anaerobic bacteria (Bacteroides spp., Clostridium spp., Peptostreptococcus spp.) and protozoa (Entamoeba histolytica, Giardia lamblia, Trichomonas vaginalis)
• Half-Life: Approximately 17–29 hours, permitting once-daily or single-dose administration
• Bioavailability: High oral bioavailability, not significantly affected by food

Benefits

• Superior Adherence: Single-dose or short-course (1–3 days) regimen drastically improves compliance compared to multi-day therapies.
• Sustained Efficacy: Extended half-life ensures therapeutic drug levels are maintained at the site of infection for prolonged periods, increasing microbiological cure rates.
• Broad-Spectrum Coverage: Effective against a range of anaerobic pathogens and protozoa, reducing the need for combination therapy.
• Convenient Administration: Oral granules can be sprinkled on soft food (e.g., yogurt, applesauce), facilitating use in pediatric, elderly, or dysphagic patients.
• Well-Tolerated Profile: Generally favorable safety and tolerability, with most adverse events being mild and self-limiting.

Common use

Secnidazole is indicated for the treatment of:

• Bacterial vaginosis in adult women
• Intestinal amoebiasis (asymptomatic and symptomatic)
• Amoebic liver abscess
• Giardiasis
• Trichomoniasis

It is also used off-label for other anaerobic infections, including those of the abdominal cavity, skin and soft tissue structures, and central nervous system, when caused by susceptible organisms.

Dosage and direction

For Bacterial Vaginosis:

• Adults: A single 2 g dose (one sachet of granules or two 1 g tablets) taken orally.

For Amoebiasis:

• Adults: 2 g once daily for 3 days.
• Children: 30 mg/kg (max 2 g) once daily for 3 days.

For Giardiasis:

• Adults: A single 2 g dose.
• Children: 30 mg/kg (max 2 g) as a single dose.

For Trichomoniasis:

• Adults: A single 2 g dose. Sexual partners should be treated concurrently.

Administration of Oral Granules:

• The entire contents of the sachet should be sprinkled onto a small amount of soft, acidic food (e.g., yogurt, applesauce, pudding) and consumed immediately without chewing or crunching the granules. It should not be mixed with liquids.

Dosage may require adjustment in severe hepatic impairment; use with caution.

Precautions

• Neurological Effects: Use with caution in patients with or at risk of central or peripheral nervous system disorders. Discontinue if abnormal neurologic signs occur.
• Hepatic Impairment: Metabolism is hepatic. Use with caution in patients with severe liver disease; consider monitoring liver function.
• Candidiasis: May result in overgrowth of non-susceptible organisms, including fungi.
• Alcohol Interaction: Avoid alcohol and products containing propylene glycol during therapy and for at least 72 hours after the last dose due to the risk of a disulfiram-like reaction (nausea, vomiting, flushing, tachycardia).
• Pregnancy: Use during pregnancy only if clearly needed. Secnidazole crosses the placental barrier. Category not established in some regions; consult prescribing information.
• Lactation: Secnidazole is excreted in human milk. Interrupt breastfeeding during treatment and for 72 hours after the dose.

Contraindications

• Hypersensitivity to secnidazole, other nitroimidazole derivatives, or any component of the formulation.
• First trimester of pregnancy (relative contraindation in many guidelines; assess risk-benefit).
• History of blood dyscrasias during previous nitroimidazole therapy.

Possible side effect

Most side effects are mild to moderate and transient. Common adverse reactions include:

• Gastrointestinal: Nausea, vomiting, abdominal pain, diarrhea, unpleasant metallic taste, dyspepsia
• Neurological: Headache, dizziness
• General: Fatigue

Less commonly reported:

• Vaginal candidiasis
• Constipation
• Allergic reactions (rash, pruritus)
• Reversible leukopenia (rare)

Drug interaction

• Alcohol & Propylene Glycol: Risk of disulfiram-like reaction (abdominal cramps, nausea, vomiting, headaches, flushing). Avoid.
• Warfarin: Secnidazole may potentiate anticoagulant effect; monitor INR closely.
• Lithium: Potential increase in lithium levels; monitor serum lithium concentrations.
• Cyclosporine: Possible increase in cyclosporine levels; monitor and adjust dose if necessary.
• Enzymes Inhibitors/Inducers: Drugs that inhibit or induce CYP450 enzymes may alter secnidazole levels, though it is primarily metabolized by non-CYP pathways.

Missed dose

Due to the typical single-dose or short-course regimen, missed doses are less common. If a dose is missed in a multi-day regimen:

• If it is near the time for the next dose, skip the missed dose and resume the regular schedule.
• Do not double the dose to make up for a missed one.
• For single-dose regimens, take as soon as remembered unless it is close to the next scheduled dose (not applicable).

Overdose

There is limited experience with secnidazole overdose. Symptoms may include:

• Enhanced adverse effects: nausea, vomiting, dizziness, ataxia
• Seizures or peripheral neuropathy (based on nitroimidazole class effects)

Management is supportive:

• Gastric lavage if presented early.
• Symptomatic treatment; no specific antidote exists.
• Monitor vital signs and provide supportive care.

Storage

• Store at room temperature (15–30°C or 59–86°F).
• Keep in the original container, protected from light and moisture.
• Keep out of reach of children and pets.

Disclaimer

This information is for educational purposes and does not replace professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider for personalized recommendations based on your health status and current medications. Do not initiate or discontinue any medication without consulting your physician.

Reviews

“Secnidazole has revolutionized our approach to treating bacterial vaginosis and protozoal infections in our clinic. The single-dose regimen dramatically improves patient compliance, and we observe high cure rates with minimal side effects. It is particularly useful in non-adherent populations.” – Dr. Elena M., Infectious Disease Specialist

“As a gastroenterologist, I find secnidazole highly effective for amoebiasis and giardiasis. The short course and tolerability make it a preferred choice, especially in children where administration with food simplifies the process.” – Dr. Rajiv K., Gastroenterologist

“From a patient perspective, being able to complete treatment in one day rather than a week is a significant benefit. The metallic taste was noticeable but a small trade-off for the convenience.” – Verified Patient